These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30019421)

  • 21. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.
    Chen YF; Madan J; Welton N; Yahaya I; Aveyard P; Bauld L; Wang D; Fry-Smith A; Munafò MR
    Health Technol Assess; 2012; 16(38):1-205, iii-v. PubMed ID: 23046909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-Effectiveness of a Health System-Based Smoking Cessation Program.
    Levy DE; Klinger EV; Linder JA; Fleegler EW; Rigotti NA; Park ER; Haas JS
    Nicotine Tob Res; 2017 Nov; 19(12):1508-1515. PubMed ID: 27639095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking Cessation therapy is a cost-effective intervention to avoid tooth loss in Brazilian subjects with periodontitis: an economic evaluation.
    Souto MLS; Carrer FCA; Braga MM; Pannuti CM
    BMC Oral Health; 2021 Dec; 21(1):616. PubMed ID: 34861866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public health impact of a novel smoking cessation outreach program in Ontario, Canada.
    Selby P; Voci S; Zawertailo L; Baliunas D; Dragonetti R; Hussain S
    BMC Public Health; 2018 Sep; 18(1):1117. PubMed ID: 30217187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of a smoking cessation program implemented at the time of surgery for lung cancer.
    Slatore CG; Au DH; Hollingworth W
    J Thorac Oncol; 2009 Apr; 4(4):499-504. PubMed ID: 19204575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
    Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
    Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of computed tomography screening for lung cancer in the United States.
    McMahon PM; Kong CY; Bouzan C; Weinstein MC; Cipriano LE; Tramontano AC; Johnson BE; Weeks JC; Gazelle GS
    J Thorac Oncol; 2011 Nov; 6(11):1841-8. PubMed ID: 21892105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial.
    Ruger JP; Weinstein MC; Hammond SK; Kearney MH; Emmons KM
    Value Health; 2008; 11(2):191-8. PubMed ID: 17854434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers.
    Howard P; Knight C; Boler A; Baker C
    Pharmacoeconomics; 2008; 26(6):497-511. PubMed ID: 18489200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis.
    Sander B; Kwong JC; Bauch CT; Maetzel A; McGeer A; Raboud JM; Krahn M
    PLoS Med; 2010 Apr; 7(4):e1000256. PubMed ID: 20386727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Effectiveness Analysis of Smoking Cessation Interventions With Behavioral Support: A Study Based on the Benefits of Smoking Cessation on Outcomes (BENESCO) Model.
    Park SK; Kang DW; Lee EK
    Nicotine Tob Res; 2022 Nov; 24(12):2011-2017. PubMed ID: 35862219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD.
    Trapero-Bertran M; Muñoz C; Coyle K; Coyle D; Lester-George A; Leidl R; Németh B; Cheung KL; Pokhrel S; Lopez-Nicolás Á
    Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):65-75. PubMed ID: 29532966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Effectiveness Analysis of Varenicline Versus Currently Funded Smoking Cessation Strategies in Brazil.
    Fernandes RRA; Seixas BV; Szklo AS; Guerra RL; Barufaldi LA; de Albuquerque RCR; de Mello Vianna CM
    Value Health Reg Issues; 2022; 27():25-31. PubMed ID: 34784545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Cost-Effectiveness Analysis of Smoking-Cessation Interventions Prior to Posterolateral Lumbar Fusion.
    Zhuang T; Ku S; Shapiro LM; Hu SS; Cabell A; Kamal RN
    J Bone Joint Surg Am; 2020 Dec; 102(23):2032-2042. PubMed ID: 33038088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of cost-effective changes to the current and potential provision of smoking cessation services: an analysis based on the EQUIPTMOD.
    Anraad C; Cheung KL; Hiligsmann M; Coyle K; Coyle D; Owen L; West R; de Vries H; Evers SM; Pokhrel S
    Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):96-105. PubMed ID: 29430762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
    Hoogendoorn M; Welsing P; Rutten-van Mölken MP
    Curr Med Res Opin; 2008 Jan; 24(1):51-61. PubMed ID: 18021492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.
    Toumazis I; de Nijs K; Cao P; Bastani M; Munshi V; Ten Haaf K; Jeon J; Gazelle GS; Feuer EJ; de Koning HJ; Meza R; Kong CY; Han SS; Plevritis SK
    JAMA Oncol; 2021 Dec; 7(12):1833-1842. PubMed ID: 34673885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
    Bolin K; Mörk AC; Willers S; Lindgren B
    Respir Med; 2008 May; 102(5):699-710. PubMed ID: 18289839
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.